EPISODE · Apr 22, 2026 · 38 MIN
Scrip M&A Podcast with Cooley Attorneys Kevin Cooper and Bill Roegge.
from Citeline Podcasts · host Norstella
Scrip Senior Writer Joseph Haas interviewed attorneys Kevin Cooper and Bill Roegge of Cooley LLP about recent events and trends in biopharmaceutical merger-and-acquisition activity. They discussed the current state of M&A after a busy conclusion to the first quarter and how that interplays with financing and partnering activity. In addition, Kevin offered tips for smaller companies to get good outcomes when dealing with large pharma firms, Bill talked about whether 2026 may be a year of competing bids in biopharma M&A and the discussion closed with a look at deals centered on platform technologies and their potential to replenish an acquirer's pipeline.
What this episode covers
Scrip Senior Writer Joseph Haas interviewed attorneys Kevin Cooper and Bill Roegge of Cooley LLP about recent events and trends in biopharmaceutical merger-and-acquisition activity. They discussed the current state of M&A after a busy conclusion to the first quarter and how that interplays with financing and partnering activity. In addition, Kevin offered tips for smaller companies to get good outcomes when dealing with large pharma firms, Bill talked about whether 2026 may be a year of competing bids in biopharma M&A and the discussion closed with a look at deals centered on platform technologies and their potential to replenish an acquirer's pipeline.
NOW PLAYING
Scrip M&A Podcast with Cooley Attorneys Kevin Cooper and Bill Roegge.
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m